Soobia Saeed

Dr. Soobia Saeed

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2024 in Journal of Health and Rehabilitation Research
Verified
Journal Article
Open access
PDF file
SSSoobia Saeed
Soobia Saeed
RGRubina Ghani
Rubina Ghani
ZSZeelaf Shahid
Zeelaf Shahid
Background: Low back pain (LBP) is a major cause of disability worldwide, affecting millions and increasing healthcare costs. Accurate assessment tools are essential for managing LBP effectively.Objective: To evaluate the effectiveness of the Low Back Outcomes Score (LBOS) and SF-36 questionnaire in assessing health status among patients with LBP across different age groups.Methods: This prospective cross-sectional study included 300 participants divided into age groups: 13-30 years, 31-50 years, and over 50 years. Data were collected using the SF-36 and LBOS questionnaires at baseline and two-year follow-up. The study measured physical, mental, and social functioning, and used statistical analysis, including regression models and Cronbach’s alpha, to evaluate internal consistency and correlation with international benchmarks.Results: The study found high internal consistency for LBOS (Cronbach’s alpha >0.7) with the lowest correlation for physical function (0.38). Significant improvements were observed across all SF-36 domains, except physical function (p < 0.05). LBOS scores showed a significant association with better psychological well-being, with mean scores of 74 (SD=55) in the excellent/good group versus 43 (SD=32) in the fair/poor group.Conclusion: LBOS and SF-36 are effective tools for assessing LBP outcomes, demonstrating good reliability and validity across different age groups in Pakistan.

1 January 2022 in Clinical Cancer Investigation Journal
Verified
Journal Article
Open access
SSSoobia Saeed
Soobia Saeed
Cancers, especially of the neural tissue, are often deemed a death sentence. However, neither the cellular and molecular mechanisms nor the underlying causes are fully defined. Despite what is currently known about various types of brain tumors, it remains poorly understood how they spread and cause collateral damage to other parts of the brain. This research focuses the cerebrospinal fluid (CSF) leakage and enzymes from brain cancer cases and various secreted proteins and enzymes within the fol

1 January 2022 in Journal of Medical Sciences and Interdisciplinary Research
Verified
Journal Article
Open access
PDF file
SSSoobia Saeed
Soobia Saeed
Cancers that affect neural tissue, particularly brain tumors, are often associated with poor prognoses. However, the precise cellular and molecular mechanisms behind their progression and associated complications remain incompletely understood. While considerable knowledge exists regarding different types of brain tumors, the processes by which they disseminate and inflict damage on adjacent brain regions are still unclear. This study examines the hypothesis that leakage of cerebrospinal fluid (CSF), along with enzymes and proteins secreted by tumor cells, may play a role in disrupting the blood-brain barrier (BBB). The research focuses on the role of CSF in brain tumors and its interaction with the BBB. The findings show that leakage typically occurs along the spinal axis, particularly in the thoracic region and the cardiorespiratory junction at the base of the brain. The study aims to identify and characterize the proteins and enzymes present in CSF by assessing: (a) the types of proteins, (b) their molecular identity, (c) their amino acid sequences, and (d) the genes responsible for their expression. In addition, this research demonstrates how tumor-derived components compromise CSF integrity and localize the specific sites of barrier disruption. The data also contribute to the identification of novel biomarkers-enzymes and toxins-released by tumor cells, providing the potential for distinguishing between normal CSF and tumor-associated proteolytic CSF profiles.

1 January 2023 in Archive of International Journal of Cancer and Allied Science
Verified
Journal Article
Open access
PDF file
SSSoobia Saeed
Soobia Saeed
AAAurazaib Abbasi
Aurazaib Abbasi
AHAbdul Sattar Muhammad Hashim
Abdul Sattar Muhammad Hashim
Although neural tissue cancers are frequently regarded as terminal, the precise origins and molecular or cellular mechanisms underlying these conditions remain elusive. Despite existing knowledge, the progression patterns and secondary effects associated with different brain tumors have not yet been fully mapped out. Cerebrospinal fluid (CSF) leakage remains a prevalent diagnostic indicator in tumor detection, and in this context, enzymes associated with brain cancer were analyzed. The primary objective of this investigation was to explore how CSF is involved in brain cancer processes and its relationship with the blood-brain barrier (BBB). The study investigated common leakage points, particularly in the thoracic spine region and at the cranial base near the cardiothoracic interface, through a systematic mapping approach. The presence of bacteria in the CSF of brain cancer patients was also investigated, aiming to identify widely used strategies for targeting cancerous cells and detecting enzymes within CSF. Further insights pinpoint specific regions where leakage occurs and highlight particular proteins and enzymes implicated in this pathological process, showing how the discharge of tumor by-products contributes to CSF damage. Consequently, this research enabled the identification of enzymes and tumor cells in CSF and introduced a novel component that characterizes tumor-associated cerebrospinal fluid.


25 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SSSoobia Saeed
Soobia Saeed
Heart disease is still at the top of the list of causes of deaths around the globe, which shows that there is a great need for early and accurate diagnostic methods that will aid clinical decision-making. A machine learning–based predictive system for heart disease will be developed and evaluated in this project using a real-world Heart Failure Prediction dataset that contains 918 anonymized patient records and 11 clinical attributes. As part of data preprocessing, medically impossible values were identified and treated, invalid cholesterol readings were replaced with the median, non-sensical entries were removed, categorical variables were encoded, and feature standardization was done to ready the dataset for model training. Accordingly, Logistic Regression, Support Vector Machine (SVM) with an RBF kernel, and Random Forest were three supervised learning algorithms implemented to evaluate their performances in binary classification. To guarantee data quality and model trustworthiness, Exploratory Data Analysis (EDA) and cross-validation were done. Model performance evaluation included the use of accuracy, precision, recall, F1-score, confusion matrices, and ROC–AUC metrics. The results indicate that the Random Forest classifier produced the best overall performance with an accuracy of 87.50%, precision of 91.59%, recall of 87.50%, F1-score of 89.50%, and an AUC of 0.9391, thus beating both SVM and Logistic Regression. Though Logistic Regression gave a comprehensible baseline, its greater false-negative rate made it less suitable for high-risk clinical applications. SVM displayed excellent non-linear classification power but needed more computational tuning. Taken together, these results show that Random Forest is the most dependable and robust model for heart disease prediction with this dataset. The next step should be incorporating wider lifestyle factors, using improved data collection methods, sophisticated outlier handling, additional machine learning models, and possibly deployment as a clinical decision-support tool through web or mobile applications.